Pär Stattin

Disclosure information not submitted.

Presentation(s):

• MP27-01: Time on treatment with abiraterone in men with de novo metastatic castration sensitive prostate cancer

  Saturday, May 14, 2022
  10:30 AM – 11:45 AM